24/7 MN – (NASDAQ: AKAN) shares are moving up more than 44% this morning, on news it plans to supply tetra for FDA trials. Shares are at $1.13 in pre-market trading. More than 11,000 trades have gone off on more than 3.7 million in volume

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug

https://www.businesswire.com/news/home/20220712005519/en/Akanda-to-Supply-Tetra-Bio-Pharma-with-Pharmaceutical-Grade-Cannabis-for-FDA-Trials-of-QIXLEEF%E2%84%A2-a-Potential-Multimillion-Dollar-Prescription-Drug

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist